City of Hope Receives $23.7 Million Grant to Map Biomarkers of Treatment

City of Hope Receives $23.7 Million Grant to Map Biomarkers of Treatment

City of Hope Secures Landmark $23.7 Million Grant to Revolutionize Immunotherapy Resistance in Non-Small Cell Lung Cancer In a groundbreaking advancement for cancer research, City of Hope, one of America’s premier cancer centers, has been awarded a contract valued at up to $23.7 million by the Advanced Research Projects Agency for Health (ARPA-H), part of the U.S. Department of Health and Human Services. This pivotal funding aims to develop a dy…

City Of Hope Secures $23.7M Grant For Lung Cancer Research

The grant will help City of Hope create a bio map of tumor changes that cause immunotherapy resistance in advanced or metastatic non-small cell lung cancer.